NCT03455166View on ClinicalTrials.gov

Identification of New Prognostic Markers in Psoriatic Arthritis

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

September 30, 2017

Conditions
PsoriasisPsoriatic Arthritis
Interventions
DIAGNOSTIC_TEST

Serum Markers

Serum Markers

All Listed Sponsors
lead

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

OTHER

NCT03455166 - Identification of New Prognostic Markers in Psoriatic Arthritis | Biotech Hunter | Biotech Hunter